The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...

The FDA is poised to issue a decision soon on KarXT, a potential first-in-class antipsychotic for schizophrenia. What should ...

The European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) recommended the granting of ...

Hetronifly in combination with chemotherapy was shown to improve survival of patients with extensive stage small cell lung ...

The European Medicines Agency approved Afqlir and Opuviz to treat age-related macular degeneration while reiterating its ...

Elahere was found to improve survival in patients with FR-alpha–positive, platinum-resistant, high-grade serous epithelial ...

"Although the effect on overall anaemia did not differ, intravenous iron reduced the prevalence of iron deficiency to a ...

The Bruton's tyrosine kinase inhibitor tolebrutinib is reportedly the first agent to show benefit in patients with nonrelapsing secondary progressive MS.

World Patient Safety Day provides an occasion to spread awareness of the medication errors that can result from products that ...

The multitarget stool DNA test was better at detecting advanced serrated colorectal lesions than other stool-based tests, a ...

A triple advantage can be achieved by shifting Mexicans' current diet toward that of the recommended Healthy and Sustainable ...

While the new Shield blood test may motivate more people to get screened for colorectal cancer, it also comes with downsides, ...